Table 6.
Measurements | Assessments | Risperidone (n=21) | Aripiprazole (n=13) | F1 | F2 | F3 |
---|---|---|---|---|---|---|
Weight | Baseline | 55.06(11.88) | 56.15(13.05) | 27.691* | 0.065 | 3.726 |
Follow up | 57.47(12.28) | 55.50(11.96) | ||||
BMI | Baseline | 20.78(4.30) | 20.73(4.23) | 26.538* | 0.308 | 3.954* |
Follow up | 22.33(4.77) | 21.06(3.84) | ||||
Waist | Baseline | 75.01(10.86) | 75.28(9.50) | 5.901* | 0.130 | 5.269* |
Follow up | 76.38(11.46) | 74.38(78.60) | ||||
Waist circumference | Baseline | 83.18(22.22) | 81.28(13.09) | 15.416* | 0.540 | 3.257 |
Follow up | 87.50(25.43) | 81.15(12.95) | ||||
Hip | Baseline | 92.65(20.73) | 91.37(11.11) | 5.3* | 0.339 | 0.120 |
Follow up | 95.28(24.14) | 91.00(11.51) |
*p<0.05; F1=Occasion Effect; F2=Group Effect; F3=Group x Occasion Effect.